Anzeige
Mehr »
Donnerstag, 16.04.2026 - Börsentäglich über 12.000 News
Gold auf 6.300 USD? Diese Aktie könnte der geheime Hebel sein
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EU6F | ISIN: DK0062498333 | Ticker-Symbol: NOV
Xetra
15.04.26 | 17:35
33,725 Euro
+1,69 % +0,560
1-Jahres-Chart
NOVO NORDISK A/S Chart 1 Jahr
5-Tage-Chart
NOVO NORDISK A/S 5-Tage-Chart
RealtimeGeldBriefZeit
34,34034,66015.04.
34,48534,54515.04.
Xetra-Umsätze heute
UhrzeitAktienkursStück
33,72516.802
33,880400
33,900549
33,90066
33,905134
33,9102
33,905160
33,900370
33,895135
33,870741
33,880400
33,90046
33,90044
33,89557
33,89035
33,880259
33,88067
33,88033
33,84083
33,850161
Tagesumsatz Xetra+0,560
+1,69 %

261.354

 Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.

Aktuelle News zur Aktie NOVO NORDISK A/S

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiSvetlana Mojsov, one of the Scientists behind Ozempic, and Mathematician Carlos Kenig, who Decoded Laws of Motion, Honored as King Faisal Prize 2026 Laureates406The Landmark 48th Session of the Prize Comes as the King Faisal Foundation Marks 50 Years of ImpactRiyadh, Saudi Arabia, April 15, 2026 (GLOBE NEWSWIRE) -- On the evening of April 15, HRH Prince Turki...
► Artikel lesen
MiThe $1 Trillion Race: Why Eli Lilly Is Leaving Novo Nordisk in the Dust71
MiGoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market40
NOVO NORDISK Aktie jetzt für 0€ handeln
MiEilmeldung am Abend: NOVO NORDISK A/S im Fokus!43
MiNVO Inks Deal With OpenAI for Speedy Drug Discovery Globally, Stock Up31
Weiter >>
2.630 Nachrichten in den letzten 12 Monaten
Das könnte Sie auch interessieren
ZeitAktuelle NachrichtenMedien
MiWayfinder Biosciences, Inc.: Wayfinder Biosciences Advances Collaboration with Daiichi Sankyo on Key Neurodegeneration Target to Second PhaseSEATTLE, April 15, 2026 /PRNewswire/ -- Wayfinder Biosciences, a biotechnology company using small molecules to target undruggable proteins at the RNA level, today...
► Artikel lesen
MiTilray Brands, Inc.: Tilray Brands Accelerates Next Phase of Global Growth and Market LeadershipNEW YORK and LEAMINGTON, Ontario, April 15, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc.?("Tilray", "our", "we" or the "Company") (NASDAQ: TLRY; TSX: TLRY), a global lifestyle and consumer packaged...
► Artikel lesen
MiTeva Pharmaceutical Industries Ltd: Teva Launches Home Ground Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care PartnersFor people living with schizophrenia who may find daily disease management overwhelming due to fragmented support and resources, Home Ground Schizophrenia Community is a centralized destination that...
► Artikel lesen
MiNRx Pharmaceuticals, Inc.: NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder ApplicationsDr. Dennis K. McBride, PhD (CAPT, Medical Service Corps, US Navy, Ret., Distinguished Research Fellow, National Defense University, and former senior executive, Office Secretary of Defense) to serve...
► Artikel lesen
MiCosmos Health Inc.: Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record GroScaled contract manufacturing division, securing long-term agreements for over 12 million unitsExpanded Sky Premium Life portfolio by 60 SKUs and accelerated global expansion, securing purchase orders...
► Artikel lesen